Key facts
- Talamo’s last known valuation is $3.2M (Apr 2025).
- It has raised $990K; the latest was Later Stage VC in Mar 2026.
- Notable investors include Deuce Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Talamo
- ·The full record, as it builds
Funding rounds
No funding rounds for Talamo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Talamo
Developer of an automated dyslexia assessment tool designed to democratize access to dyslexia assessment and to empower more individuals to realize their potential. The company's tool generates a report filled with personalized insights including the risk of dyslexia, the child's strengths and challenges, and recommendations, thus helping parents improve their child's educational and life outcomes.
- Sector
- Healthcare
- HQ
- Plymouth, United Kingdom
- Founded
- 2021
- Employees
- 9
- Website
- talamo.co.uk/
- Ownership
- Privately Held (backing)
Talamo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Talamo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Talamo in its N-PORT filings yet. We sweep new filings monthly.